MRKR Marker Therapeutics Inc

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

SCHEDULE 14A

 

Proxy Statement Pursuant to Section 14(a) of the

Securities Exchange Act of 1934

(Amendment No.    )

 

Filed by the Registrant   x

Filed by a party other than the Registrant   ¨

 

Check the appropriate box:

 

¨	Preliminary Proxy Statement
¨	Confidential, for use of the Commission Only (as permitted by Rule 14a-6(e)(2))
¨	Definitive Proxy Statement
x	Definitive Additional Materials
¨	Soliciting Material Pursuant to §240.14a-12

 

Marker Therapeutics, Inc.

(Name of Registrant as Specified In Its Charter)

 

(Name of Person(s) Filing Proxy Statement, if Other Than the Registrant)

 

Payment of Filing Fee (Check the appropriate box):    

 

x	No Fee Required
¨	Fee computed on table below per Exchange Act Rules 14a-6(i)(4) and 0-11.

 

	(1)	Title of each class of securities to which transaction applies:
	(2)	Aggregate number of securities to which transaction applies:
	(3)	Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):
	(4)	Proposed maximum aggregate value of transaction:
	(5)	Total fee paid:

 

¨	Fee paid previously with preliminary materials.
¨	Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.

 

	(1)	Amount Previously Paid:
	(2)	Form Schedule or Registration Statement No.:
	(3)	Filing Party:
	(4)	Date Filed:

 

 

 

CONTROL ID:

 

MARKER THERAPEUTICS, INC.

 

IMPORTANT NOTICE REGARDING THE AVAILABILITY OF PROXY MATERIALS
FOR THE ANNUAL MEETING OF STOCKHOLDERS

DATE: MAY 9, 2019

 

TIME: 8:00 AM (LOCAL TIME)

 

LOCATION: PILLSBURY WINTHROP SHAW PITTMAN LLP, TWO HOUSTON CENTER, 909 FANNIN ST, SUITE 2000, HOUSTON, TEXAS 77010

 

THIS COMMUNICATION REPRESENTS A NOTICE TO ACCESS A COMPLETE SET OF PROXY MATERIALS AVAILABLE TO YOU ON THE INTERNET. WE ENCOURAGE YOU TO ACCESS AND REVIEW ALL OF THE IMPORTANT INFORMATION CONTAINED IN THE PROXY MATERIALS BEFORE VOTING. THE PROXY MATERIALS ARE AVAILABLE AT: http://www.proxyandprinting.com .

 

.

IF YOU DECIDE TO VIEW THE PROXY MATERIALS AND VOTE YOUR SHARES ONLINE:

Step 1: Go to http://www.proxyandprinting.com .

Step 2: Click the “Vote Your Proxy” link.

Step 3: Click on the logo of Marker Therapeutics, Inc.

Step 4: To view or download the proxy materials, click on the link that describes the material you wish to view or download. For example, to

view or download the Proxy Statement, click on the “Proxy Statement” link.

Step 5: To vote online, click on the designated link and follow the on-screen instructions. YOU MAY VOTE ONLINE UNTIL 10:00 AM EASTERN TIME ON MAY 8, 2019.

 

·

IF YOU WANT TO RECEIVE A PAPER COPY OF THE PROXY MATERIALS INCLUDING THE PROXY CARD, YOU MUST REQUEST ONE. THERE IS NO CHARGE TO YOU FOR REQUESTING A COPY. TO FACILITATE TIMELY DELIVERY PLEASE MAKE THE REQUEST, AS INSTRUCTED BELOW, BEFORE APRIL 22, 2019 .

 

HOW TO REQUEST PAPER COPIES OF OUR MATERIALS

 

PHONE:	FAX:	INTERNET:	EMAIL:
CALL TOLL FREE	SEND THIS CARD TO	www.proxyandprinting.com	akotlova@islandstocktransfer.com
1-877-502-0550	1-727-289-0069	FOLLOW THE ON-SCREEN	INCLUDE YOUR CONTROL ID IN
		INSTRUCTIONS.	YOUR EMAIL.

 

HOW TO ATTEND THE MEETING AND VOTE IN PERSON: PLEASE COME TO PILLSBURY WINTHROP SHAW PITTMAN LLP, TWO HOUSTON CENTER, 909 FANNIN ST, SUITE 2000, HOUSTON, TEXAS 7701 0

 

 

VOTING ITEMS

 

 

THE BOARD OF DIRECTORS RECOMMENDS THAT YOU VOTE “FOR” THE ELECTION OF EACH OF THE FOLLOWING NOMINEES FOR THE BOARD OF DIRECTORS PRESENTED UNDER PROPOSAL 1:

1.

Election of Director Nominees –Frederick Wasserman, David Laskow-Pooley, John Wilson, David Eansor, Juan Vera and Peter Hoang.

 

THE BOARD OF DIRECTORS RECOMMENDS THAT YOU VOTE “FOR” EACH OF THE FOLLOWING PROPOSALS:

2.

Advisory vote on executive compensation.

 

3.

Ratification of the appointment of Marcum LLP as the Company’s independent auditors for the year ending December 31, 2019.

 

 

THE BOARD OF DIRECTORS HAS FIXED THE CLOSE OF BUSINESS ON MARCH 18, 2019 AS THE RECORD DATE FOR THE DETERMINATION OF STOCKHOLDERS ENTITLED TO RECEIVE NOTICE OF THE ANNUAL MEETING AND TO VOTE AT THE MEETING OR ANY POSTPONEMENT OR ADJOURNMENT OF THE MEETING.

 

PLEASE NOTE – THIS IS NOT A PROXY CARD - YOU CANNOT VOTE BY RETURNING THIS CARD. TO VOTE YOUR

SHARES, YOU MUST
VOTE ONLINE OR REQUEST A PAPER COPY OF OUR PROXY MATERIALS TO RECEIVE A PROXY CARD.

 

IF YOU WISH TO ATTEND AND VOTE AT THE MEETING, PLEASE BRING THIS NOTICE.

 

YOUR VOTE IS IMPORTANT!